Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?

NCT00560339 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2007-11-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether there is a relationship between serial B-natriuretic peptide (BNP) and implantable device measured intrathoracic impedance in symptomatic and asymptomatic heart failure patients over a 1-year period. Furthermore, this study will establish whether implantable device measured intrathoracic impedance trends with the distance walked on a six-minute hall walk (6MHW), an exercise-based acute measure that has also been associated with heart failure clinical status.

Conditions

  • Congestive Heart Failure

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY
  • Southern New Jersey Cardiac Specialists

    lead OTHER

Principal Investigators

  • John Andriulli, DO · Southern New Jersey Cardiac Specialists

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2009-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00560339 on ClinicalTrials.gov